Avoid Dishman Pharma, says SP Tulsian

SP Tulsian, sptulsian.com don’t think that Dishman Pharma can correct below Rs 84-85. He feels the major correction seems to have got factored in. However, he still feels one should not invest in Dishman Pharma even at current levels.

Tulsian told CNBC-TV18, “Two stocks, Dishman Pharma and Shasun Pharma both have disappointed to a great extent because the kind of frenzy or the up move or the liking for the stock which we had seen about couple of quarters back and that time also things were very cautious.”
He further added, “Dishman Pharma has given very good results about two quarters back and since then people have been taking the call but I don’t think that the stock can correct below Rs 84-85 or so because the major correction seems to have got factored in but not reliable stocks to track and look to invest into.”